Automated CPR Devices Market Size & Share Growth Forecast Report (2026-2035)

Automated CPR Devices Market Overview

The automated CPR devices market was valued at USD 226 million in 2025 and is estimated at USD 244.4 million in 2026. Under the proposed VynZ Research forecast scenario, the market could reach USD 542.1 million by 2035, representing a CAGR of 9.4% from 2026 to 2035.

Market growth is supported by demand for consistent chest compressions in selected high-acuity situations, increased use during patient transport, and investment in emergency medical equipment. The American Heart Association’s 2025 CPR and Emergency Cardiovascular Care Guidelines state that mechanical CPR devices should not be used routinely for every adult cardiac arrest, but may be considered where high-quality manual compressions are difficult or unsafe. This guidance supports selective adoption rather than universal deployment.

Research Methodology

The VynZ Research team assessed published market estimates, product segmentation, manufacturer information, clinical guidance, regulatory records, and recent deployment announcements. The analysis considers device type, power source, application, end user, and regional demand. The 2025 baseline is used to calculate segment revenue estimates consistently. Where published sources do not provide comparable market shares or growth rates, figures are identified as VynZ Research estimates rather than independently verified market statistics.

Research Highlights

• Piston-driven devices accounted for an estimated 66.9% of the market in 2025, supported by their established use in hospitals and emergency medical services.
• Battery-electric systems represented 59.3% of the market in 2025,reflecting their portability and suitability for emergency transport.
• Hospitals held 5.18% of revenue in 2025 due to use in selected emergency, critical-care, and procedural settings.
• Load-distributing band devices are forecast to record a 7.93% CAGR from 2026 to 2035, reflecting demand for alternative mechanical compression designs.
• North America accounted for 39.9% of the market in 2025 due to established emergency medical services and hospital purchasing capacity.

Automated CPR Devices Market Dynamics

Market Trends

The market is moving toward portable, battery-powered systems that can sustain chest compressions during ambulance transfers, air-medical transport, and selected hospital procedures. Battery-electric designs reduce reliance on compressed-gas supplies and can simplify deployment where equipment must be moved between clinical environments. Piston-driven devices remain established products, while load-distributing band systems provide an alternative compression mechanism. These differences influence purchasing decisions according to the clinical setting, patient-handling requirements, and available staff. Another important trend is more selective procurement based on clinical protocols, safety, training, and lifecycle costs.

Growth Drivers

The need to maintain chest compressions during difficult transfers is a key demand driver. Air-medical teams may face practical limitations when providing manual CPR while keeping personnel secured during flight. In 2025, Air Methods announced nationwide deployment of ZOLL AutoPulse NXT across its community-based aircraft, highlighting transport safety and continuity of compressions as reasons for adoption. Such deployments demonstrate demand in specialized emergency settings rather than routine use across every resuscitation case. Hospitals and emergency medical services also consider mechanical systems for prolonged resuscitation, procedures in which manual compression is difficult, and situations with limited personnel. However, clinical guidance remains an important influence on purchasing decisions. The International Liaison Committee on Resuscitation advises against routine replacement of manual chest compressions with automated mechanical devices, while allowing consideration when sustained high-quality manual CPR is impractical or unsafe.

Market Restraints / Challenges

High acquisition and ownership costs can limit adoption, particularly among emergency services with low annual cardiac-arrest volumes. Expenses may include the device, batteries, patient-interface consumables, preventive maintenance, staff training, and servicing. Buyers must assess these costs against the narrower clinical situations in which mechanical CPR is appropriate. The Canadian Agency for Drugs and Technologies in Health’s 2025 review discusses uncertainty in clinical effectiveness and cost-effectiveness, which can make large-scale procurement more difficult to justify. Clinical risks and deployment interruptions also constrain demand. The American Heart Association’s 2025 guidelines do not recommend routine mechanical CPR for adult cardiac arrest, citing evidence that has not demonstrated improved survival over manual compressions in unselected cases.

Market Opportunities

The strongest opportunities are in transport-focused emergency services, rural or remote response systems, and hospital procedures where sustained manual compressions are difficult. Air-medical operators may value systems that allow crews to maintain safer working positions during flight. Hospitals may also consider mechanical compression equipment for selected catheterization-laboratory and prolonged-resuscitation cases, provided the use is consistent with clinical guidance and deployment procedures. Manufacturers can also compete through simpler deployment, portability, battery performance, maintenance support, staff training, and reliable consumable supply. The FDA’s device surveillance and recall framework makes product quality and field support commercially important alongside device performance.

Global Automated CPR Devices Market Report Coverage

Automated CPR Devices Market Segmentation

By Device Type

Piston-driven devices accounted for an estimated 66.9% share in 2025, making them the largest device-type segment. Their established position is supported by their use in hospital resuscitation and emergency medical services, where a mechanical piston provides repeated compressions.

Load-distributing band devices segment’s proposed growth rate is 7.93% CAGR through 2035, reflecting opportunities in selected transport and limited-personnel applications.

By Power Source

Battery-electric configurations held an estimated 59.3% share in 2025. Their leading position reflects portability and their suitability for mobile emergency care, where staff may need to move equipment between the scene, ambulance, aircraft, and hospital.

Pneumatic or oxygen-driven systems are projected to grow at an estimated 5.2% CAGR during 2026–2035, as they continue to serve settings where compatible gas infrastructure and established operating procedures are available.

By Application

Emergency medical transport represented 40% of 2025 revenue reflecting demand in ambulance and air-medical settings where manual compressions may be difficult to sustain safely.

Hospital resuscitation is estimated to grow at 6.6% during the study period indicating the potential for selected-use adoption rather than routine deployment.

By End User

Hospitals accounted for an estimated 50.18% of 2025 revenue, making them the largest end-user segment. Demand is associated with selected emergency-department, critical-care, and procedural scenarios in which maintaining high-quality manual compressions may be difficult.

Emergency medical services are projected to record the fastest end-user growth at 8.1% CAGR during 2026 to 2035. EMS demand is supported by the practical challenges of maintaining compressions during patient transport and when staffing is limited.

Regional Insights

North America

North America accounted for an estimated 39.9% of the market in 2025, making it the largest regional market. Demand is supported by established emergency medical services, hospital infrastructure, and use of mechanical CPR in selected transport and high-acuity situations. The region is expected to record a proposed 8.5% CAGR from 2026 to 2035. The U.S. Food and Drug Administration’s device oversight and post-market surveillance processes influence product safety, quality assurance, and purchasing confidence. However, the American Heart Association’s 2025 guidance against routine use in every adult cardiac arrest means that adoption will depend on clinical protocols and suitable use cases rather than universal deployment.

Europe

Europe represented an estimated 23% share in 2025. Demand is associated with established hospital systems, ambulance services, and specialist emergency-care capabilities. For the 2026–2035 period, a 9.4% CAGR for Europe is estimated. Adoption opportunities are strongest where medical teams need to maintain compressions during transport or selected procedures. Clinical guidance from the International Liaison Committee on Resuscitation supports considering automated mechanical devices when sustained high-quality manual CPR is impractical or unsafe, while discouraging routine replacement of manual compressions. This approach encourages targeted purchasing and training.

Asia Pacific

Asia Pacific accounted for an estimated 25% share in 2025. Demand is supported by investment in emergency medical infrastructure, hospital services, and ambulance capabilities across diverse healthcare systems. Differences in procurement budgets and access to specialist emergency care mean that market development is likely to vary considerably by country. The region is projected to record the fastest growth among the four regional groupings in this scenario. Growth will depend on the expansion of emergency response capacity, affordability, staff training, and local service networks. Because clinical recommendations do not support routine use in every cardiac arrest, buyers are likely to assess mechanical CPR equipment for specific operational needs rather than treating it as a universal replacement for manual CPR.

Rest of World

Rest of World held an estimated 12.1% share in 2025. This category combines Latin America, the Middle East, Africa, and other markets outside the three regions above. Demand is influenced by the availability of emergency medical services, hospital budgets, access to imported equipment, and the presence of local distributors able to provide maintenance and training. The group is projected to grow as investment opportunities are likely to be concentrated in major hospitals, specialist emergency services, and air-medical operators with clear requirements for uninterrupted compressions during transport.

Competitive Landscape / Company Insights

The automated CPR devices market is moderately concentrated, with established suppliers competing through device design, reliability, clinical usability, servicing, and institutional relationships. Stryker’s LUCAS and ZOLL’s AutoPulse are prominent systems, while SCHILLER and Defibtech also have products identified in the Canadian Agency for Drugs and Technologies in Health’s review of licensed automated chest compression devices. The FDA’s 2025 AutoPulse NXT recall illustrates the importance of quality control and post-market monitoring. Clinical guidelines also shape competition by limiting routine use and focusing purchasing on selected applications.

Mini Profiles

Bexen Cardio supplies emergency and resuscitation equipment for professional healthcare settings. Its market position depends on product reliability, regulatory compliance, distributor support, and the ability to serve institutional buyers.

Corpuls develops emergency medical equipment and monitoring solutions for professional responders. Its broader emergency-care portfolio places it within the competitive environment for equipment used by ambulance services and hospital teams.

Inovytec develops emergency medical technologies intended for use by healthcare professionals and first responders. Its positioning reflects demand for portable equipment, practical deployment, and solutions suited to time-sensitive emergency care.

Michigan Instruments develops respiratory and resuscitation-related equipment, including systems used in clinical and training environments. Product engineering and specialist applications support its position in the wider resuscitation equipment ecosystem.

CU Medical Systems supplies emergency cardiac-care products, including defibrillation equipment. Its competitive position is influenced by device usability, regulatory compliance, service support, and access to hospital and emergency-service procurement channels.

Key Players

• Air Methods
• Bexen
• Cardio
• Corpuls
• CU Medical Systems
• Defibtech
• Inovytec
• Michigan Instruments
• SCHILLER
• Stryker
• ZOLL Medical Corporation

Recent Developments

Air Methods announced nationwide integration of the ZOLL AutoPulse NXT automated CPR device across its community-based aircraft. The deployment targets situations where continuous compressions are difficult to provide manually while maintaining crew safety during flight.

Defibtech announced the end of its Lifeline ARM product line’s long-term service plans after July 2025, while identifying ARM XR as the replacement device. The transition highlights the importance of product lifecycle planning, service availability, and continued consumable support for installed equipment.

SCHILLER introduced the ARGUS PRO LifeCare 3 monitor-defibrillator with self-testing, rapid startup, and optional CPR feedback functionality. Although it is not an automated chest-compression device, the launch reflects ongoing development in the wider emergency resuscitation equipment market.

Stryker’s LUCAS Chest Compression System was introduced at Abrazo Central Campus for use in its emergency department and critical-care units. The hospital’s deployment illustrates continued institutional adoption for selected cases involving prolonged resuscitation and situations where consistent compressions are difficult to sustain manually.

ZOLL Medical Corporation faced a U.S. FDA Class I recall involving the AutoPulse NXT Resuscitation System, with the recall initiated in 2025. The event underscores the importance of product quality, risk management, and post-market monitoring in a market where reliability is essential to clinical use.

Table of Contents for Automated CPR Devices Market Report

1.    Research Overview

        1.1.    The Report Offers
        1.2.    Market Coverage
                  1.2.1.    By Device Type 
                  1.2.2.    By Power Source 
                  1.2.3.    By Application 
                  1.2.4.    By End User 
        1.3.    Research Phases
        1.4.    Limitations
        1.5.    Market Methodology
                  1.5.1.  Data Sources
                             1.5.1.1. Primary Research
                             1.5.1.2. Secondary Research
                  1.5.2.  Methodology
                             1.5.2.1. Data Exploration
                             1.5.2.2. Forecast Parameters
                             1.5.2.3. Data Validation
                             1.5.2.4. Assumptions
                  1.5.3.  Study Period & Data Reporting Unit

2.    Executive Summary

3.    Industry Overview

       3.1.    Industry Dynamics
                 3.1.1.    Market Growth Drivers
                 3.1.2.    Market Restraints
                 3.1.3.    Key Market Trends
                 3.1.4.    Major Opportunities
       3.2.    Industry Ecosystem
                 3.2.1.    Porter’s Five Forces Analysis
                 3.2.2.    Recent Development Analysis
                 3.2.3.    Value Chain Analysis
       3.3.    Competitive Insight
                 3.3.1.    Competitive Position of Industry Players
                 3.3.2.    Market Attractive Analysis
                 3.3.3.    Market Share Analysis

4.    Global Market Estimate and Forecast

       4.1.    Global Market Overview
       4.2.    Global Market Estimate and Forecast to 2035

5.    Market Segmentation Estimate and Forecast

       5.1.    By Device Type 
                 5.1.1. Piston-driven devices
                           5.1.1.1. Market Definition
                           5.1.1.2. Market Estimation and Forecast to 2035
                 5.1.2. Load-distributing band devices
                           5.1.2.1. Market Definition
                           5.1.2.2. Market Estimation and Forecast to 2035

       5.2.    By Power Source 
                 5.2.1. Battery-electric
                           5.2.1.1. Market Definition
                           5.2.1.2. Market Estimation and Forecast to 2035
                 5.2.2. Pneumatic/oxygen-driven
                           5.2.2.1. Market Definition
                           5.2.2.2. Market Estimation and Forecast to 2035

       5.3.    By Application 
                 5.3.1. Emergency medical transport
                           5.3.1.1. Market Definition
                           5.3.1.2. Market Estimation and Forecast to 2035
                 5.3.2. Hospital resuscitation
                           5.3.2.1. Market Definition
                           5.3.2.2. Market Estimation and Forecast to 2035
                 5.3.3. Catheterization-laboratory and procedural use
                           5.3.3.1. Market Definition
                           5.3.3.2. Market Estimation and Forecast to 2035
                 5.3.4. Other specialized settings
                           5.3.4.1. Market Definition
                           5.3.4.2. Market Estimation and Forecast to 2035

       5.4.    By End User 
                 5.4.1. Hospitals
                           5.4.1.1. Market Definition
                           5.4.1.2. Market Estimation and Forecast to 2035
                 5.4.2. Emergency medical services providers
                           5.4.2.1. Market Definition
                           5.4.2.2. Market Estimation and Forecast to 2035
                 5.4.3. Military and defense
                           5.4.3.1. Market Definition
                           5.4.3.2. Market Estimation and Forecast to 2035
                 5.4.4. Ambulatory surgical centers and specialty clinics
                           5.4.4.1. Market Definition
                           5.4.4.2. Market Estimation and Forecast to 2035

6.   North America Market Estimate and Forecast

      6.1.    By Device Type   
      6.2.    By Power Source   
      6.3.    By Application   
      6.4.    By End User   
                6.4.1.     U.S. Market Estimate and Forecast
                6.4.2.     Canada Market Estimate and Forecast
                6.4.3.     Mexico Market Estimate and Forecast

7.   Europe Market Estimate and Forecast

      7.1.    By Device Type   
      7.2.    By Power Source   
      7.3.    By Application   
      7.4.    By End User   
                7.4.1.     Germany Market Estimate and Forecast
                7.4.2.     France Market Estimate and Forecast
                7.4.3.     U.K. Market Estimate and Forecast
                7.4.4.     Italy Market Estimate and Forecast
                7.4.5.     Spain Market Estimate and Forecast
                7.4.6.     Russia Market Estimate and Forecast
                7.4.7.     Rest of Europe Market Estimate and Forecast

8.   Asia-Pacific (APAC) Market Estimate and Forecast

      8.1.    By Device Type   
      8.2.    By Power Source   
      8.3.    By Application   
      8.4.    By End User   
                8.4.1.     China Market Estimate and Forecast
                8.4.2.     Japan Market Estimate and Forecast
                8.4.3.     India Market Estimate and Forecast
                8.4.4.     South Korea Market Estimate and Forecast
                8.4.5.     Rest of Asia-Pacific Market Estimate and Forecast

9.   Rest of the World (RoW) Market Estimate and Forecast

      9.1.    By Device Type   
      9.2.    By Power Source   
      9.3.    By Application   
      9.4.    By End User   
                9.4.1.     Brazil Market Estimate and Forecast
                9.4.2.     Saudi Arabia Market Estimate and Forecast
                9.4.3.     South Africa Market Estimate and Forecast
                9.4.4.     U.A.E. Market Estimate and Forecast
                9.4.5.     Other Countries Market Estimate and Forecast

10.  Company Profiles

       10.1.   Air Methods
                  10.1.1.    Snapshot
                  10.1.2.    Overview
                  10.1.3.    Offerings
                  10.1.4.    Financial Insight
                  10.1.5.    Recent Developments
       10.2.   Bexen Cardio
                  10.2.1.    Snapshot
                  10.2.2.    Overview
                  10.2.3.    Offerings
                  10.2.4.    Financial Insight
                  10.2.5.    Recent Developments
       10.3.   Corpuls
                  10.3.1.    Snapshot
                  10.3.2.    Overview
                  10.3.3.    Offerings
                  10.3.4.    Financial Insight
                  10.3.5.    Recent Developments
       10.4.   CU Medical Systems
                  10.4.1.    Snapshot
                  10.4.2.    Overview
                  10.4.3.    Offerings
                  10.4.4.    Financial Insight
                  10.4.5.    Recent Developments
       10.5.   Defibtech
                  10.5.1.    Snapshot
                  10.5.2.    Overview
                  10.5.3.    Offerings
                  10.5.4.    Financial Insight
                  10.5.5.    Recent Developments
       10.6.   Inovytec
                  10.6.1.    Snapshot
                  10.6.2.    Overview
                  10.6.3.    Offerings
                  10.6.4.    Financial Insight
                  10.6.5.    Recent Developments
       10.7.   Michigan Instruments
                  10.7.1.    Snapshot
                  10.7.2.    Overview
                  10.7.3.    Offerings
                  10.7.4.    Financial Insight
                  10.7.5.    Recent Developments
       10.8.   SCHILLER
                  10.8.1.    Snapshot
                  10.8.2.    Overview
                  10.8.3.    Offerings
                  10.8.4.    Financial Insight
                  10.8.5.    Recent Developments
       10.9.   Stryker
                  10.9.1.    Snapshot
                  10.9.2.    Overview
                  10.9.3.    Offerings
                  10.9.4.    Financial Insight
                  10.9.5.    Recent Developments
       10.10.   ZOLL Medical Corporation
                  10.10.1.    Snapshot
                  10.10.2.    Overview
                  10.10.3.    Offerings
                  10.10.4.    Financial Insight
                  10.10.5.    Recent Developments

11.    Appendix

         11.1.    Exchange Rates
         11.2.    Abbreviations

Note: Financial insight and recent developments of different companies are subject to the availability of information in the secondary domain.